During the past decade, Private Educational Institution of Higher Education "Medical University "REAVIZ" conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "BeiGene" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" are "Ulcerative Colitis" (6 trials), "Crohn Disease" (2 trials), "Colitis, Ulcerative" (1 trials), "Gastric, or Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" in a lesser frequency.

Most popular intervention types in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (4 trials), "RPC1063" (2 trials), "5-FU" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Private Educational Institution of Higher Education "Medical University "REAVIZ"" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Private Educational Institution of Higher Education "Medical University "REAVIZ"". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Private Educational Institution of Higher Education "Medical University "REAVIZ", undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Private Educational Institution of Higher Education "Medical University "REAVIZ", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".